[{"Assets_0_FY_USD":70283000000.0,"CommonStockSharesOutstanding_0_FY_shares":1308000000.0,"Dividends_4_FY_USD":2742000000.0,"EarningsPerShareBasic_1_FY_USD":-2.96,"EarningsPerShareBasic_4_FY_USD":3.54,"EarningsPerShareDiluted_1_FY_USD":-2.96,"EarningsPerShareDiluted_4_FY_USD":3.51,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":11898000000.0,"NetIncomeLoss_1_FY_USD":-3865000000.0,"NetIncomeLoss_4_FY_USD":4628000000.0,"StockholdersEquity_0_FY_USD":20442000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":1319000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":1307000000.0,"Ticker":"GILD","CIK":"882095","name":"GILEAD SCIENCES INC","OfficialName":"Gilead Sciences Inc. Common Stock","form":"10-K","period":"20171231","fy":"2017.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"78838305412.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20180227"}]